Table 2B. Results of molecular and immunological analyses of GBS and control patients in French Polynesia 2013-2014.
Dengue IgG (MIA) and neutralizing responses (Neut)
| IgG Dengue n (%) |
Dengue Neut. n (%) | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GBSa |
CTR1 |
CTR2 |
||||||||||||||||||
| IgG Z-b | IgG Z+b | Total | IgG Z- | IgG Z+ | Total | IgG Z- | IgG Z+ | Total | GBS | |||||||||||
| ≥ 2 serotypes | 11 | (84.6) | 25 | (86.2) | 36 | (85.7) | 42 | (57.5) | 23 | (92.0) | 65 | (66.3) | 42 | (64.6) | 4 | (80.0) | 46 | (65.8) | 41 | (100) |
| 1 serotype | 0 | - | 4 | (13.8) | 4 | (9.5) | 20 | (27.4) | 2 | (8.0) | 22 | (22.5) | 11 | (16.9) | 1 | (20.0) | 12 | (17.1) | 0 | - |
| No infection | 2 | (15.4) | 0 | - | 2 | (4.8) | 11 | (15.1) | 0 | - | 11 | (11.2) | 12 | (18.5) | 0 | - | 12 | (17.1) | 0 | - |
| 13 | 29 | 42 | 73 | 25 | 98 | 65 | 5 | 70 | 41 | |||||||||||
a
tested samples for GBS patients are late samples (±3 months after admission)
b
IgG Z- and IgG Z+ mean samples IgG (MIA) negative and positive for ZIKV, respectively.